Home About us Current issue Ahead of Print Back issues Submission Instructions Advertise Contact Login   

Search Article 
Advanced search 
Saudi Journal of Kidney Diseases and Transplantation
Users online: 183 Home Bookmark this page Print this page Email this page Small font sizeDefault font size Increase font size 

SPECIAL ARTICLE Table of Contents   
Year : 2014  |  Volume : 25  |  Issue : 1  |  Page : 133-148
Adaptation and Implementation of the "Kidney Disease: Improving Global Outcomes (KDIGO)" Guidelines for Evaluation and Management of Mineral and Bone Disorders in Chronic Kidney Disease for Practice in the Middle East Countries

1 Dubai Medical College, Dubai, United Arab Emirates
2 Nephrology Unit, Jahra Hospital, Kuwait
3 Nephrology Division, Tawam Hospital, Al Ain, United Arab Emirates
4 Renal Unit, Guy's and St. Thomas' NHS Foundation Hospital, London, United Kingdom
5 Lebanese University, Beirut, Division of Nephrology, Lebanon
6 AlAzhar University, Cairo, Egypt
7 Medical Affairs, SANOFI Middle East, Dubai, United Arab Emirates
8 University of Tehran, Tehran, Iran
9 Saudi Center for Organ Transplantation, Riyadh, Kingdom of Saudi Arabia

Correspondence Address:
Mona Al Rukhaimi
Dubai Medical College, P.O. Box 22331, Dubai
United Arab Emirates
Login to access the Email id

DOI: 10.4103/1319-2442.124536

PMID: 24434398

Rights and Permissions

This review presents the views of an expert group of nephrologists from the Middle East along with an international expert on adaptation and implementation of the 2009 Kidney Disease: Improving Global Outcomes (KDIGO) guidelines for evaluation and manage­ment of mineral and bone disorders in chronic kidney disease (CKD-MBD) for practice in the Middle East countries. The members of the panel examined the KDIGO guidelines and formulated recommendations that can be implemented practically for the management of CKD-MBD in the Middle East. There was a broad agreement on most of the recommendations made by the KDIGO work-group. However, the panelists commented on specific areas and amplified certain concepts that might help the nephrologists in the Middle East. The final document was reviewed by all participants as well as by members of the Middle East task force implementation group for KDIGO guidelines. Their comments were incorporated. The guideline statements are presented along with detailed rationale and relevant discussion as well as limitations of the evidence. The panel recognized the need to upgrade the suggestion of KDIGO related to lateral abdominal radiograph and echocardiogram in patients with CKD stages 3-5D into a stronger recommendation. The panel underlined the risk of hyper-phosphatemia to CKD-MBD and the importance of prompt initiation or modification of therapy according to rising trends in para­thyroid hormone level. They recommended the use of non-calcium-based phosphate binders as the first-line therapy in CKD patients with signs of vascular calcification. The panel agreed that all aspects of the KDIGO recommendations concerning bone biopsy, evaluation and treatment of bone disease after kidney trans­plantation should be implemented as such.

Print this article  Email this article

  Similar in PUBMED
    Search Pubmed for
    Search in Google Scholar for
   Citation Manager
  Access Statistics
   Reader Comments
   Email Alert *
   Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded924    
    Comments [Add]    

Recommend this journal